121 related articles for article (PubMed ID: 11786275)
1. [(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers.
Ravert HT; Scheffel U; Mathews WB; Musachio JL; Dannals RF
Nucl Med Biol; 2002 Jan; 29(1):47-53. PubMed ID: 11786275
[TBL] [Abstract][Full Text] [Related]
2. [11C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)-methyl]-1- piperazinecarboxylate ([11C]GR89696): synthesis and in vivo binding to kappa opiate receptors.
Ravert HT; Mathews WB; Musachio JL; Scheffel U; Finley P; Dannals RF
Nucl Med Biol; 1999 Oct; 26(7):737-41. PubMed ID: 10628552
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and stereoselective kappa-receptor binding of methylated analogues of GR-89.696.
Röhr C; Soukara S; Wünsch B
Eur J Med Chem; 2001 Feb; 36(2):211-4. PubMed ID: 11311752
[TBL] [Abstract][Full Text] [Related]
4. 11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.
Talbot PS; Narendran R; Butelman ER; Huang Y; Ngo K; Slifstein M; Martinez D; Laruelle M; Hwang DR
J Nucl Med; 2005 Mar; 46(3):484-94. PubMed ID: 15750163
[TBL] [Abstract][Full Text] [Related]
5. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
[TBL] [Abstract][Full Text] [Related]
8. Region-dependent G-protein activation by kappa-opioid receptor agonists in the mouse brain.
Mizoguchi H; Leitermann RJ; Narita M; Nagase H; Suzuki T; Tseng LF
Neurosci Lett; 2004 Feb; 356(2):145-7. PubMed ID: 14746884
[TBL] [Abstract][Full Text] [Related]
9. A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines.
Naylor A; Judd DB; Lloyd JE; Scopes DI; Hayes AG; Birch PJ
J Med Chem; 1993 Jul; 36(15):2075-83. PubMed ID: 8393489
[TBL] [Abstract][Full Text] [Related]
10. Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.
Remmers AE; Clark MJ; Mansour A; Akil H; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1999 Feb; 288(2):827-33. PubMed ID: 9918595
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
12. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
13. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
[TBL] [Abstract][Full Text] [Related]
14. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
[TBL] [Abstract][Full Text] [Related]
15. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the kappa-opioid receptor-selective tracer [(11)C]GR103545 in awake rhesus macaques.
Schoultz BW; Hjornevik T; Willoch F; Marton J; Noda A; Murakami Y; Miyoshi S; Nishimura S; Arstad E; Drzezga A; Matsunari I; Henriksen G
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1174-80. PubMed ID: 20157708
[TBL] [Abstract][Full Text] [Related]
17. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
18. A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists.
Olmsted SL; Takemori AE; Portoghese PS
J Med Chem; 1993 Jan; 36(1):179-80. PubMed ID: 8380614
[No Abstract] [Full Text] [Related]
19. Modulation of kappa-mediated antitussive activity in rats by a delta-agonist.
Kamei J; Tanihara H; Kasuya Y
Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):375-8. PubMed ID: 1321982
[TBL] [Abstract][Full Text] [Related]
20. Tritiated kappa receptor antagonist norbinal torphimine: synthesis and in vitro binding in three different tissues.
Márki A; Otvös F; Tóth G; Hosztafi S; Borsodi A
Life Sci; 2000; 66(1):43-9. PubMed ID: 10658923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
